if the failure rate plus the rate of occurrence of rash , which necessitated discontinuing the drug , are combined , it appears that 8.8 % of the patients were at a disadvantage receiving sulfamethoxazole compared to 9.7 % for the combination of sulfamethoxazole plus trimethoprim .
C0038689
sulfamethoxazole
C0041044
combination